# Reference List - ALS Longitude Prize Application

**Format:** Harvard Referencing Style  
**Numbering:** Consecutive [1], [2], [3] in order of appearance

---

## References

[1] Nguyen, E., et al. (2024). Evo 2: Genome modeling at scale. Arc Institute.

[2] Our validation study (in preparation). Multi-modal foundation models for therapeutic target discovery.

[3] Abramson, J., et al. (2024). Accurate structure prediction of biomolecular interactions with AlphaFold 3. *Nature*.

[4] Taylor, J.P., Brown, R.H. & Cleveland, D.W. (2016). Decoding ALS: from genes to mechanism. *Nature*, 539(7628), 197-206.

[5] DeJesus-Hernandez, M., et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. *Neuron*, 72(2), 245-256.

[6] Jumper, J., et al. (2021). Highly accurate protein structure prediction with AlphaFold. *Nature*, 596(7873), 583-589.

[7] Brown, R.H. & Al-Chalabi, A. (2017). Amyotrophic lateral sclerosis. *New England Journal of Medicine*, 377(2), 162-172.

[8] Project MinE ALS Sequencing Consortium (2018). Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. *European Journal of Human Genetics*, 26(10), 1537-1546.

[9] DiMasi, J.A., Grabowski, H.G. & Hansen, R.W. (2016). Innovation in the pharmaceutical industry: new estimates of R&D costs. *Journal of Health Economics*, 47, 20-33.

[10] Wong, C.H., Siah, K.W. & Lo, A.W. (2019). Estimation of clinical trial success rates and related parameters. *Biostatistics*, 20(2), 273-286.

[11] Nameem, R. (2025). Clinical Advisor. Personal communication. [Email: nayeem.rahima@gmail.com]

[12] Jheeta, R. (2025). Research Advisor. Personal communication. [Email: rjhetam@gmail.com]

---

## Notes for PDF Conversion

- Convert this markdown to PDF format
- Ensure all references are numbered consecutively [1] through [12]
- Maintain Harvard referencing style formatting
- Include full contact information for personal communications (references [11] and [12])

---

**Alternative Format for Team Members (if preferred):**

If Dr. Nameem and Dr. Jheeta are team members rather than cited references, they should be listed in the **Part B, Section 2.1 (Team Expertise)** section with their CVs attached, rather than in the reference list.

If they are external collaborators or advisors being cited, the format above is appropriate.

